Cipla Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: CIPLA BSE: 500087

₹1346.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #5 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited (this stock)	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹108,498 Cr

EV / EBITDA

22.9x

EV / Sales

5.71x

Market cap / Sales

5.72x

Earnings yield

2.83%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 5,320 Cr, up 0.1% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 862 Cr, down 33.8% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	5,078	1,154	862	₹10.6700
March 31, 2026	4,210	522	385	₹4.7600
Dec. 31, 2025	4,498	736	617	₹7.6400
Sept. 30, 2025	5,226	1,633	1,211	₹14.9900
June 30, 2025	5,046	1,744	1,303	₹16.1300
March 31, 2025	4,798	1,756	1,485	₹18.3900
Dec. 31, 2024	4,971	1,704	1,438	₹17.8100
Sept. 30, 2024	4,775	1,578	1,178	₹14.5900
June 30, 2024	4,501	1,430	1,056	₹13.0800
March 31, 2024	4,037	1,224	1,038	₹12.1600
Dec. 31, 2023	4,381	1,381	1,114	₹12.6100
Sept. 30, 2023	4,665	1,397	1,030	₹12.7600
June 30, 2023	4,318	1,226	895	₹11.0900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	5,320	4,390	4,915	5,480	5,317	5,091	5,160	5,064	4,715	4,575	4,550	4,870	4,476
Operating revenue	5,078	4,210	4,498	5,226	5,046	4,798	4,971	4,775	4,501	4,037	4,381	4,665	4,318
Other income	243	180	417	255	271	293	189	289	214	539	169	205	158
Operating expenses	3,992	3,643	3,777	3,703	3,422	3,479	3,309	3,337	3,141	3,209	3,025	3,286	3,114
Operating profit	1,086	567	721	1,523	1,624	1,319	1,662	1,438	1,360	828	1,356	1,379	1,205
Operating profit margin	21.4%	13.5%	16.0%	29.1%	32.2%	27.5%	33.4%	30.1%	30.2%	20.5%	30.9%	29.6%	27.9%
Depreciation	169	218	153	141	146	148	143	146	138	137	135	180	136
Interest	6	7	4	3	6	3	4	3	5	5	9	8	0
Exceptional items, gain / (loss)	—	—	-244	—	—	295	—	—	—	—	—	—	—
Profit before tax	1,154	522	736	1,633	1,744	1,756	1,704	1,578	1,430	1,224	1,381	1,397	1,226
Tax	291	138	119	423	441	270	266	400	375	242	363	367	331
Net profit	862	385	617	1,211	1,303	1,485	1,438	1,178	1,056	—	—	1,030	895
EPS	10.67	4.76	7.64	14.99	16.13	18.39	17.81	14.59	13.08	12.16	12.61	12.76	11.09
Net profit (TTM)	3,074	3,515	4,616	5,437	5,405	5,158	—	—	—	—	—	2,959	—
EPS (TTM)	38.06	43.52	57.15	67.32	66.92	63.87	57.64	52.44	50.61	48.62	40.86	36.66	32.64

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	18,980	4,636	3,515
March 31, 2025	19,045	6,469	5,158
March 31, 2024	16,574	4,947	4,077
March 31, 2023	15,791	3,441	2,513

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	7.4%	7.3%	20,103^†	20,030^†	17,645^†	16,247^†	15,521^†	14,131^†	13,552^†	12,952^†	11,780^†	11,065^†
Operating revenue	6.3%	6.4%	18,980	19,045	16,574	15,791	14,854^†	13,901^†	12,659^†	12,374^†	11,445^†	10,925^†
Other income	—	—	1,123^†	985^†	1,071^†	457^†	667^†	230^†	893^†	578^†	335^†	139^†
Operating expenses	—	—	14,545^†	13,266^†	12,633^†	11,445^†	11,298^†	10,179^†	9,952^†	9,872^†	—	9,303^†
Operating profit	0.7%	3.6%	4,435^†	5,778^†	3,941^†	4,345^†	3,556^†	3,722^†	2,707^†	2,502^†	—	1,622^†
Operating profit margin	—	—	23.4%^†	30.3%^†	23.8%^†	27.5%^†	23.9%^†	26.8%^†	21.4%^†	20.2%^†	—	14.8%^†
Depreciation	—	—	658^†	574^†	588^†	575^†	527^†	556^†	600^†	570^†	—	500^†
Interest	—	—	19^†	15^†	23^†	27^†	27^†	45^†	36^†	17^†	12^†	39^†
Exceptional items, gain / (loss)	—	—	-244^†	295^†	0^†	-186^†	0^†	0^†	0^†	0^†	-78^†	0^†
Profit before tax	10.5%	6.7%	4,636	6,469	4,947	3,441	3,669^†	3,351^†	2,964^†	2,493^†	1,911^†	1,187^†
Tax	—	—	1,121^†	1,311^†	1,304^†	942^†	888^†	882^†	646^†	604^†	443^†	212^†
Net profit	11.8%	7.3%	3,515	5,158	4,077	2,513	—	2,468^†	2,318^†	1,888^†	1,469^†	975^†
EPS	13.8%	7.3%	43.52^†	63.87^†	48.62^†	29.53^†	34.48^†	30.62^†	28.76^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	23.4%^†	30.3%^†	23.8%^†	27.5%^†	23.9%^†	26.8%^†	21.4%^†	20.2%^†	—	14.8%^†
EBIT margin	24.5%^†	34.0%^†	30.0%^†	22.0%^†	24.9%^†	24.4%^†	23.7%^†	20.3%^†	16.8%^†	11.2%^†
PBT margin	24.4%	34.0%	29.8%	21.8%	24.7%^†	24.1%^†	23.4%^†	20.1%^†	16.7%^†	10.9%^†
Net margin	18.5%	27.1%	24.6%	15.9%	—	17.8%^†	18.3%^†	15.3%^†	12.8%^†	8.9%^†
Interest coverage	241.20x^†	429.12x^†	219.70x^†	128.33x^†	137.24x^†	75.34x^†	83.23x^†	147.90x^†	161.62x^†	31.40x^†
Dividend payout	29.9%^†	20.4%^†	17.5%^†	16.9%^†	14.5%^†	0.0%^†	20.9%^†	—	—	—
Earnings retention	70.1%^†	79.6%^†	82.5%^†	83.1%^†	85.5%^†	100.0%^†	79.1%^†	—	—	—
Current ratio	4.63x	5.77x	—	—	—	—	—	—	—	—
Quick ratio	3.50x	4.64x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	10.3%	16.1%	—	—	—	—	—	—	—	—
Return on assets	9.1%	14.5%	—	—	—	—	—	—	—	—
Return on capital employed	13.4%^†	20.0%^†	—	—	—	—	—	—	—	—
Asset turnover	0.49x	0.54x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	2,832	-1,344	-1,322	781	2,051
March 31, 2025	3,301	-2,309	-1,074	571	2,730
March 31, 2024	3,727	-2,883	-709	550	3,176
March 31, 2023	3,035	-2,758	-425	586	2,449
March 31, 2022	2,773	-2,464	-427	305	2,468

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	38,493	34,201	34,040	11	0	17,912	3,872	249	3,782	4,354
March 31, 2025	35,566	32,099	31,938	0	0	18,369	3,183	83	3,508	3,607
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.